Glaxo Covers All Its Bases For Xenical Through Rx Co-Promotion Deal
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline is hedging its bets on OTC Xenical with a U.S. co-promotion deal with Roche for a prescription dose of the weight-loss drug